Publication Type Journal Article
Title Methyl-cyclopentadienyl Ruthenium Compounds with 2,2?-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential
Authors Leonor Côrte-Real Ricardo G. Teixeira Patricia Girio Elisabeta Comsa Alexis Moreno Rachad Nasr Hélène Baubichon-Cortay Fernando Avecilla Fernanda M. Marques M Paula Robalo Paulo Mendes Joao P. Prates Ramalho M. Helena Garcia Pierre Falson Andreia Valente
Groups BIOIN
Journal Inorganic Chemistry
Year 2018
Month April
Volume
Number
Pages
Abstract New ruthenium methyl-cyclopentadienyl compounds bearing bipyridine derivatives with the general formula [Ru(?5-MeCp)(PPh3)(4,4?-R-2,2?-bpy)]+ (Ru1, R = H; Ru2, R = CH3; and Ru3, R = CH2OH) have been synthesized and characterized by spectroscopic and analytical techniques. Ru1 crystallized in the monoclinic P21/c, Ru2 in the triclinic P1?, and Ru3 in the monoclinic P21/n space group. In all molecular structures, the ruthenium center adopts a “piano stool” distribution. Density functional theory calculations were performed for all complexes, and the results support spectroscopic data. Ru1 and Ru3 were poor substrates of the main multidrug resistance human pumps, ABCB1, ABCG2, ABCC1, and ABCC2, while Ru2 displayed inhibitory properties of ABCC1 and ABCC2 pumps. Importantly, all compounds displayed a very high cytotoxic profile for ovarian cancer cells (sensitive and resistant) that was much more pronounced than that observed with cisplatin, making them very promising anticancer agents.
DOI http://dx.doi.org/10.1021/acs.inorgchem.8b00358
ISBN
Publisher
Book Title
ISSN
EISSN
Conference Name
Bibtex ID
Observations
Back to Publications List